1 citations
,
May 2025 in “Archives of Dermatological Research” This study found that microinfusion of 0.5% minoxidil in the scalp led to a significant reduction in diastolic blood pressure, indicating systemic absorption, while the control group experienced a rise in systolic pressure possibly due to procedural pain.
September 2024 in “Journal of Skin and Stem Cell” In this study, a combination treatment of microinfusion (MMP®) and topical minoxidil showed a modest increase in hair density in a 28-year-old woman with chronic telogen effluvium, particularly in the parieto-vertex region, suggesting potential benefits but underscoring the need for larger trials to confirm efficacy.
April 2025 in “Research Square (Research Square)” This study found that microinfusion of minoxidil into the scalp was associated with a reduction in diastolic blood pressure, indicating systemic absorption of the drug.
5 citations
,
January 2016 in “Surgical and Cosmetic Dermatology” December 2022 in “Zenodo (CERN European Organization for Nuclear Research)” In this study, among patients with androgenetic alopecia, combining microneedling with minoxidil led to the best improvement in hair loss and volume compared to using microneedling or minoxidil alone.